Comparison Between a New PSA Assay With the Well-Established Beckman Coulter Immunoassay: A Preliminary Report
{{output}}
Prostate-specific antigen (PSA) is a critical biomarker for prostate cancer (PCa) patient clinical management. In this study, we sought to compare three different immunoassays (CLIA): Beckman Coulter Access Hybritech (PSA-B) (reference method), Immulite 2000 P... ...
